Join to View Full Profile
2 Medical Plaza DrSte 180Roseville, CA 95661
Phone+1 916-781-1225
Fax+1 916-797-4799
Dr. Rosenthal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Seth Rosenthal is a radiation oncologist in Roseville, CA and is affiliated with multiple hospitals in the area, including Marshall Medical Center, Mercy General Hospital, Mercy Hospital of Folsom, Mercy San Juan Medical Center, Sutter Auburn Faith Hospital, Sutter Davis Hospital, Sutter Medical Center, Sacramento, Sutter Roseville Medical Center, Mercy Medical Center Mount Shasta, and Sutter Roseville Medical Center. He received his medical degree from Yale School of Medicine and has been in practice 30 years. He specializes in urologic cancer and is experienced in prostate cancer. He has more than 100 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 1988 - 1991
Yale-New Haven Medical CenterInternship, Internal Medicine, 1987 - 1988
Yale School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1991 - 2028
PA State Medical License 1988 - 2026
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2013, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2016-2017
Clinical Trials
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
- Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer Start of enrollment: 2005 Dec 01
Publications & Presentations
PubMed
- Experience-driven perceptions misalign with assessed heat risk in the United States.Jennifer R Marlon, Nicolas Begotka, Annie Preston, Max Steifel, Jesse M Keenan
Nature Communications. 2025-12-24 - 3 citationsLong-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postpros...Himanshu R Lukka, Stephanie L Pugh, William U Shipley, Pierre P Major, Oliver Sartor
International Journal of Radiation Oncology, Biology, Physics. 2025-11-15 - Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy.Emily Chan, Stephanie L Pugh, Jeffry P Simko, Felix Feng, William U Shipley
The Prostate. 2025-10-01
Authored Content
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
Press Mentions
RTOG Foundation Establishes Four New Committees; Names Committee LeadersAugust 5th, 2022
Should Adjuvant Chemo Be Added to Treatment in Early High-Risk Prostate Cancer?April 8th, 2019
Modest Effects of Intense Therapy for Prostate CaMarch 19th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
